Page last updated: 2024-10-25

cystamine and Neurodegenerative Diseases

cystamine has been researched along with Neurodegenerative Diseases in 3 studies

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
"Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by a progressive and specific loss of certain brain cell populations."6.47Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. ( Cicchetti, F; Gibrat, C, 2011)
"Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by a progressive and specific loss of certain brain cell populations."2.47Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. ( Cicchetti, F; Gibrat, C, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibrat, C1
Cicchetti, F1
Gentile, V1
Cooper, AJ1
Igarashi, S1
Koide, R1
Shimohata, T1
Yamada, M1
Hayashi, Y1
Takano, H1
Date, H1
Oyake, M1
Sato, T1
Sato, A1
Egawa, S1
Ikeuchi, T1
Tanaka, H1
Nakano, R1
Tanaka, K1
Hozumi, I1
Inuzuka, T1
Takahashi, H1
Tsuji, S1

Reviews

2 reviews available for cystamine and Neurodegenerative Diseases

ArticleYear
Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Mar-30, Volume: 35, Issue:2

    Topics: Animals; Cystamine; Cysteamine; Disease Models, Animal; Enzyme Inhibitors; Humans; Huntington Diseas

2011
Transglutaminases - possible drug targets in human diseases.
    Current drug targets. CNS and neurological disorders, 2004, Volume: 3, Issue:2

    Topics: Animals; Brain; Celiac Disease; Cystamine; Enzyme Inhibitors; Humans; Mice; Mice, Transgenic; Neurod

2004

Other Studies

1 other study available for cystamine and Neurodegenerative Diseases

ArticleYear
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.
    Nature genetics, 1998, Volume: 18, Issue:2

    Topics: Animals; Apoptosis; Base Sequence; Cadaverine; COS Cells; Cystamine; DNA Primers; Enzyme Inhibitors;

1998